Elixir Licenses Novel Growth Hormone From Bristol-Myers Squibb

Elixir Pharmaceuticals announced an exclusive license agreement with Bristol-Myers Squibb Company for worldwide development and commercialization rights to Bristol-Myers Squibb's growth hormone secretagogue (GHS), BMS-604992, and five related compounds. BMS-604992 is a novel, orally available compound that stimulates the body's release of growth hormone.

Yahoo News (http://biz.yahoo.com/bw/050428/285070.html?.v=1)